देश: आयरलैंड
भाषा: अंग्रेज़ी
स्रोत: HPRA (Health Products Regulatory Authority)
Povidone-iodine
Ayrton Saunders Ltd
D08AG; D08AG02
Povidone-iodine
40 milligram(s)/millilitre
Cutaneous solution
Product not subject to medical prescription
Iodine products; povidone-iodine
Not marketed
1975-11-25
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Betadine Skin Cleanser 40mg/ml cutaneous solution 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains 40 mg povidone iodine. For excipients see Section 6.1. 3 PHARMACEUTICAL FORM Cutaneous Solution. Golden brown, clear viscous liquid. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For the disinfection and cleansing of skin in the management of superficial infections. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Apply to thoroughly wet skin, then rinse, twice daily or as directed by a physician. 4.3 CONTRAINDICATIONS Use in patients with hypersensitivity to iodine. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE Use of the preparation may interfere with tests of thyroid function. If there is aggravation of the condition or no improvement consult the doctor. 4.5 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERACTION None stated. 4.6 FERTILITY, PREGNANCY AND LACTATION Regular use of povidone-iodine should be avoided in pregnant or lactating women as absorbed iodine can cross the placental barrier and can be secreted into breast milk. 4.7 EFFECTS ON ABILITY TO DRIVE AND USE MACHINES None known. 4.8 UNDESIRABLE EFFECTS Use of this preparation may interfere with tests of thyroid function. I R I S H M E D I C I N E S B O A R D ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ _ _P_ _r_ _i_ _n_ _t_ _e_ _d_ _ _ _2_ _2_ _/_ _1_ _2_ _/_ _2_ _0_ _1_ _1_ _C_ _R_ _N_ _ _ _2_ _1_ _0_ _6_ _4_ _2_ _7_ _p_ _a_ _g_ _e_ _ _ _n_ _u_ _m_ _b_ _e_ _r_ _:_ _ _ _1_ 4.9 OVERDOSE In the case of accidental ingestion of l पूरा दस्तावेज़ पढ़ें